Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor
Dopamine receptor agonists are used for the treatment of various psychiatric diseases. Here, the authors screen approximately three million compounds and identify a novel class of D1R agonists that do not have a catechol scaffold and possess promising pharmacokinetic properties.
Enregistré dans:
Auteurs principaux: | David L. Gray, John A. Allen, Scot Mente, Rebecca E. O’Connor, George J. DeMarco, Ivan Efremov, Patrick Tierney, Dmitri Volfson, Jennifer Davoren, Edward Guilmette, Michelle Salafia, Rouba Kozak, Michael D. Ehlers |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8a74eb3e0a2d4c1fa0ce2b3e319fdc9f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Effects of a Novel Non-catechol Dopamine Partial Agonist on Working Memory in the Aged Rhesus Monkey
par: Tara L. Moore, et autres
Publié: (2021) -
Crystal structure of dopamine D1 receptor in complex with G protein and a non-catechol agonist
par: Bingfa Sun, et autres
Publié: (2021) -
Potential link between genetic polymorphisms of catechol-O-methyltransferase and dopamine receptors and treatment efficacy of risperidone on schizophrenia
par: Han JY, et autres
Publié: (2017) -
Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT1 receptor with protective action in cardiac hypertrophy
par: Larissa B. Teixeira, et autres
Publié: (2017) -
Agonist dependency of the second phase access of β-arrestin 2 to the heteromeric µ-V1b receptor
par: Nuttawadee Ngamlertwong, et autres
Publié: (2021)